In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37 (original) (raw)

Therapeutic Action of Antimicrobial Cathelicidin Peptide LL-37 on a Murine Sepsis Model

Juntendo Medical Journal, 2020

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model

International Journal of Molecular Sciences, 2020

Augmentation of the Lipopolysaccharide-Neutralizing Activities of Human Cathelicidin CAP18/LL-37-Derived Antimicrobial Peptides by Replacement with Hydrophobic and Cationic Amino Acid Residues

Isao Nagaoka

Clinical and Vaccine Immunology, 2002

View PDFchevron_right

Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application

Amon Wafelman

Peptides, 2006

View PDFchevron_right

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37

Dr. Priyanka Adhikari

RSC Advances

View PDFchevron_right

Antimicrobial and Membrane Disrupting Activities of a Peptide Derived from the Human Cathelicidin Antimicrobial Peptide LL37

Sathiah .Thennarasu

Biophysical Journal, 2010

View PDFchevron_right

Antimicrobial peptides: the LPS connection

Andrea C. Rinaldi

Methods in molecular biology (Clifton, N.J.), 2010

View PDFchevron_right

Human cathelicidin antimicrobial peptide LL-37

Kazuhiko Okumura

2000

View PDFchevron_right

Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats

Isao Nagaoka

Pediatric Surgery International, 2005

View PDFchevron_right

Structure and Function of a Potent Lipopolysaccharide-Binding Antimicrobial and Anti-inflammatory Peptide

Lin Wei

Journal of Medicinal Chemistry, 2013

View PDFchevron_right

New Antiseptic Peptides To Protect against Endotoxin-Mediated Shock

Guillermo Uzcategui Tejada

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

In vitro and in vivo antimicrobial activity of two α-helical cathelicidin peptides and of their synthetic analogs

Barbara Skerlavaj, Monica Benincasa, Renato Gennaro

2003

View PDFchevron_right

Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells

Isao Nagaoka

International Immunology, 2011

View PDFchevron_right

LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria

Barbara Skerlavaj

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

The human cathelicidin LL-37 — A pore-forming antibacterial peptide and host-cell modulator

Alessandro Tossi

Biochimica et Biophysica Acta (BBA) - Biomembranes, 2016

View PDFchevron_right

Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice

Isao Nagaoka

International immunology, 2016

View PDFchevron_right

Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein

Wim Buurman

The Journal of Immunology, 2000

View PDFchevron_right

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds

insan syah

Frontiers in immunology, 2013

View PDFchevron_right

Antibacterial action of synthetic anti-lipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxins

Jochen Behrends

The FEBS Journal

View PDFchevron_right

Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism

Isao Nagaoka

PLoS ONE, 2014

View PDFchevron_right

Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity

Ziv Oren, Jeffrey Lerman

Biochemical Journal, 1999

View PDFchevron_right

Cationic amphipathic peptide analogs of cathelicidin LL‐37 as a probe in the development of antimicrobial/anticancer agents

Marilena Lekka

Journal of Peptide Science, 2020

View PDFchevron_right

Biological Characterization of Two Novel Cathelicidin-derived Peptides and Identification of Structural Requirements for Their Antimicrobial and Cell Lytic Activities

Renato Gennaro

Journal of Biological Chemistry, 1996

View PDFchevron_right

Small AntiMicrobial Peptide with In Vivo Activity Against Sepsis

Claire Lacombe

Molecules, 2019

View PDFchevron_right

Anti-inflammatory Properties of Antimicrobial Peptides and Peptidomimetics: LPS and LTA Neutralization

Henrik Franzyk

Methods in molecular biology (Clifton, N.J.), 2017

View PDFchevron_right

Lipid Segregation Explains Selective Toxicity of a Series of Fragments Derived from the Human Cathelicidin LL-37

Bob Berno

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens

Sunithi Gunasekera

Cellular and Molecular Life Sciences

View PDFchevron_right

Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37

Kurt Berndt

Journal of Biological Chemistry, 1998

View PDFchevron_right

Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity

Mahsa Abdolhosseini

Peptides, 2012

View PDFchevron_right

A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo

Chiara Falciani

The FASEB Journal, 2010

View PDFchevron_right

Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide

Michel Koch

Biochemical Pharmacology, 2004

View PDFchevron_right

Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37

Richard Epand

RSC advances, 2013

View PDFchevron_right

Cathelicidin Peptide Sheep Myeloid Antimicrobial Peptide-29 Prevents Endotoxin-induced Mortality in Rat Models of Septic Shock

C. Silvestri

American Journal of Respiratory and Critical Care Medicine, 2004

View PDFchevron_right

Human Host Defense Cathelicidin Peptide LL-37 Enhances the Lipopolysaccharide Uptake by Liver Sinusoidal Endothelial Cells without Cell Activation

Isao Nagaoka

Journal of immunology (Baltimore, Md. : 1950), 2016

View PDFchevron_right

Recombinant production of human antimicrobial peptide LL- 37 and its secondary structure

Lukáš Vacek

View PDFchevron_right

In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37 (original) (raw)

Related papers